Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-24.29%
↓ 27% below average
Average (9y)
-19.18%
Historical baseline
Range
High:2.54%
Low:-60.86%
CAGR
+23.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -24.29% | -130.0% |
| 2023 | -10.56% | -22.0% |
| 2022 | -8.66% | -440.3% |
| 2021 | 2.54% | +132.8% |
| 2020 | -7.76% | +59.0% |
| 2019 | -18.91% | +68.9% |
| 2018 | -60.86% | -135.9% |
| 2017 | -25.80% | +23.6% |
| 2016 | -33.79% | -815.4% |
| 2015 | -3.69% | - |